Similar articles

• Novel dihydropyridine thioglycosides and their corresponding dehydrogenated forms as potent anti-hepatocellular carcinoma agents.

  Elgemeie GH, El-Naggar DH. Elgemeie GH, et al. Nucleosides Nucleotides Nucleic Acids. 2018;37(4):199-216. doi: 10.1080/15257770.2018.1457161. Epub 2018 May 3. Nucleosides Nucleotides Nucleic Acids. 2018. PMID: 29723119
• Potentiation of DNA damage and cytotoxicity by calmodulin antagonists.

  Rosenthal SA, Hait WN. Rosenthal SA, et al. Yale J Biol Med. 1988 Jan-Feb;61(1):39-49. Yale J Biol Med. 1988. PMID: 2452522 Free PMC article. Review.
• Anti-breast cancer activity of some novel 1,2-dihydropyridine, thiophene and thiazole derivatives.

  Al-Said MS, Bashandy MS, Al-Qasoumi SI, Ghorab MM. Al-Said MS, et al. Eur J Med Chem. 2011 Jan;46(1):137-41. doi: 10.1016/j.ejmech.2010.10.024. Epub 2010 Oct 29. Eur J Med Chem. 2011. PMID: 21093116
• Inhibition of calmodulin function by CV-159, a novel dihydropyridine compound.

  Umekawa H, Yamakawa K, Nunoki K, Taira N, Tanaka T, Hidaka H. Umekawa H, et al. Biochem Pharmacol. 1988 Sep 15;37(18):3377-81. doi: 10.1016/0006-2952(88)90685-5. Biochem Pharmacol. 1988. PMID: 2844186
• Multidrug resistance.

  Fine RL, Chabner BA. Fine RL, et al. Cancer Chemother Biol Response Modif. 1987;9:81-92. Cancer Chemother Biol Response Modif. 1987. PMID: 2908588 Review. No abstract available.